Stockreport

Xilio Therapeutics to Present at the Leerink Partners Global Healthcare Conference

Xilio Therapeutics, Inc.  (XLO) 
PDF WALTHAM, Mass., March 02, 2026 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing masked imm [Read more]